Snapshot img

US Cannabis Market Size 2025-2029

The US cannabis market size is forecast to increase by USD 141.48 billion billion at a CAGR of 37.1% between 2024 and 2029.

The US cannabis market is experiencing significant growth driven by key demographic trends and advancements in research and production of medical marijuana. The millennial population, the largest consumer demographic in the US, is increasingly embracing cannabis use, particularly for medicinal purposes. This shift in consumer behavior is fueling market expansion in states with legal medical and recreational marijuana programs. Furthermore, the investment landscape is evolving, with an increase in funding for research and production of medical cannabis. This influx of capital is enabling companies to innovate and improve product offerings, as well as expand their reach and distribution networks.
However, challenges persist, including accessibility issues and high prices associated with medical cannabis. As the market continues to mature, companies must navigate these challenges effectively to capitalize on growth opportunities and maintain a competitive edge. Strategic partnerships, operational efficiency, and a focus on patient care and education will be essential for success in this dynamic and rapidly evolving industry.

What will be the size of the US Cannabis Market during the forecast period?

Request Free Sample

The cannabis market in the US is experiencing significant growth and transformation, driven by increasing legalization efforts and shifting consumer preferences. The market encompasses a range of cannabis products, including flowering plants and derivatives such as CBD-related items, cannabis-infused edibles, beverages, vapes, and extracts. Medical marijuana continues to gain traction due to its therapeutic applications for conditions like chronic pain and multiple sclerosis. Legalization for recreational use is expanding, leading to the proliferation of dispensaries and online sales. Regulatory changes and consumer adoption are fostering innovation in product development, from cannabis oils(Cannabinoids) to advanced cannabis-infused beverages and edibles.
Social acceptance is on the rise, with millennials leading the charge. Industrial hemp cultivation is also contributing to the market's expansion, with applications ranging from textiles to CBD production. Overall, the cannabis market is poised for continued growth and evolution, shaped by regulatory developments, consumer trends, and product innovation.

How is this market segmented?

The market research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2025-2029, as well as historical data from 2019-2023 for the following segments.

Derivative Type

  CBD
  THC
  Balanced THC and CBD


Product

  Medical
  Recreational


Source

  Marijuana
  Hemp


Geography

  US

By Derivative Type Insights

The cbd segment is estimated to witness significant growth during the forecast period.

The CBD segment is projected to dominate the US cannabis market due to the federal legality of hemp-derived CBD oil. This trend is driven by relaxing government norms regarding CBD usage in most states and at the federal level. As of 2024, Georgia and Indiana allow hemp-derived CBD oil for medicinal purposes, with THC content restrictions. Marijuana legalization for medicinal and recreational use varies across states, leading to the growth of medical marijuana dispensaries and the production of marijuana flower, CO2 oil, butane hash oil, live resin, and ice water hash. The market encompasses a range of consumable products, including edibles, infused beverages, and vapes, as well as topical products and medical hemp.

While some consumers use cannabis for mind-altering effects, others seek therapeutic applications for medical indications such as chronic pain, multiple sclerosis, and neurological health management. Cannabidiol (CBD) is a major component of medical cannabis, offering potential benefits for mental health management and pain relief. However, the market faces challenges related to packaging-related modifications, inhalation hazards, and social stigma. Despite these challenges, the market is expected to grow, driven by increasing acceptance of cannabis for medicinal and recreational use.

Get a glance at the market share of various segments Request Free Sample

The CBD segment was valued at USD 8.76 billion in 2019 and showed a gradual increase during the forecast period.

Market Dynamics

Our researchers analyzed the data with 2024 as the base year, along with the key drivers, trends, and challenges. A holistic analysis of drivers will help companies refine their marketing strategies to gain a competitive advantage.

What are the key market drivers leading to the rise in adoption of US Cannabis Market?

Growing millennial populati

The projected number of cannabis users is projected to increase significantly by the year 2025. As of 2016, the value of the cannabis market attributable to medical use was about 4.7 billion U.S. dollars. By 2025, the projected market value for medical cannabis is estimated to be over 13 billion U.S. dollars. In recent years the cannabis market has grown significantly in the U.S. and is anticipated to grow outside of the U.S. as well.

Economic benefits from the cannabis industry

One of the potential economic benefits from the cannabis market is the potential to generate taxable revenue for states. The value of taxable revenue generated by cannabis sales is expected to grow significantly in the coming years. Another benefit of the cannabis industry is the potential for job creation and growth. The estimated number of jobs that will be created by the U.S. marijuana industry is expected to exceed 280 thousand in the next few years.

Consumers and opinions

Consumers are an important part of the cannabis market growth in the U.S. The number of U.S. adults that had used marijuana within their lifetimes has been increasing in recent years. Cannabis can be used in a variety of forms with many methods for consumption. The most common form of marijuana consumed in the U.S. in recent years was cannabis flower, followed by edibles. Marijuana can also be purchased or acquired through a variety of channels. A majority of adults in the U.S. in recent years had purchased their marijuana from a recreation facility.

The Cannabis Industry Report is Segmented by Product Type (Capsules, Concentrates, Edibles, and Other Product Types), Application (Medical and Recreational), Compound Type (Tetrahydrocannabinol (THC), Cannabidiol (CBD), and Balanced THC and CBD), and Geography (North America, Europe, Asia-Pacific, South America, and Middle East and Africa). The Report Offers Market Size and Forecasts for all the Above Segments in Value (USD).

California was the largest market for recreational cannabis sales in the United States in 2023. In that year, recreational sales in the state reached 5.3 billion U.S. dollars. Michigan was the second largest market with sales of 2.9 billion dollars.

In the United States, sales of legal recreational cannabis are expected to reach nearly 58 billion U.S. dollars by 2030. Legal marijuana sales are forecast to increase steadily with each consecutive year. Sales per state The number of cannabis consumers is likewise expected to grow in the United States: by 2025, the country is projected to have close to 50 million consumers. In 2018, the state of California was by far the leading American state in terms of legal, as well as illicit cannabis sales. The market for recreational marijuana in California amounted to some five and a half billion U.S. dollars in 2018. This was more than double the market size of New York. By 2024, the recreational cannabis market in California is forecast to reach 7.2 billion dollars. Opinions on legalization In 2020, more than two-thirds of adult Americans believed cannabis should be made legal in the United States. Over the past decades, public support for the legalization of the soft drug has increased significantly. In 2003, only about a third of Americans were in favor of legalization, while more than 60 percent of the population was against it.

Snapshot img

Marijuana Market Size 2024-2028

The marijuana market size is forecast to increase by USD 87.8 billion at a CAGR of 32.14% between 2023 and 2028.

The market is experiencing significant growth due to the increasing legalization of cannabis for medical and recreational use in various regions. This trend is further fueled by the expansion of the e-commerce industry, enabling easier access to cannabis-infused edible products, CBD oil, and other cannabinoid-based offerings. However, the market also faces challenges such as the potential side effects associated with inappropriate use of medical marijuana and the need for effective pest control solutions to ensure product quality and safety. The cannabis industry is evolving rapidly, with a focus on innovation and compliance to meet the growing demand for CBD and other cannabinoid-based products.

What will be the Size of the Marijuana Market During the Forecast Period?

Request Free Sample

The market encompasses a diverse range of products derived from the Cannabis plant, including flowers, concentrates, edibles, topicals and tinctures. Two primary types of cannabis are commonly recognized: Cannabis sativa and Cannabis indica. THC (tetrahydrocannabinol) and CBD (cannabidiol) are the most prominent cannabinoids, with THC producing psychoactive effects and CBD offering therapeutic benefits. Medical cannabis and recreational cannabis are the two primary market segments. Medical cannabis is used to alleviate symptoms of various conditions, such as chemotherapy-induced nausea, while recreational cannabis is consumed for its psychoactive properties. CBD products, such as CBD gummies, have gained popularity due to their non-psychoactive nature and potential health benefits.
The market is continually evolving, with new products and innovations emerging regularly. Cannabinoids, including CBD (Epidiolex) and THC (Sativex, Marinol, Syndros, and others), are being developed and marketed as pharmaceuticals. The cannabis market is experiencing significant growth and is expected to continue expanding due to increasing legalization, consumer demand, and ongoing research and development.

How is this Marijuana Industry segmented and which is the largest segment?

The marijuana industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Medical marijuana
  Recreational marijuana


Type

  Oil and tinctures
  Flower


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  APAC



  South America



  Middle East and Africa

By Product Insights

The medical marijuana segment is estimated to witness significant growth during the forecast period. Medical marijuana is experiencing significant growth In the US market due to its potential therapeutic benefits for various health conditions. Chronic pain, including neuropathic and inflammatory pain, is one of the primary conditions treated with marijuana. The increasing prevalence of chronic pain among adults and the popularity of medical marijuana as a pain reliever are driving market expansion. Additionally, medical marijuana has shown promise in alleviating nausea caused by conditions such as Crohn's disease, acute gastritis, hypoglycemia, panic disorder, and arachnoiditis. Marijuana plants used for medicinal purposes include Cannabis indica, Cannabis sativa, and hybrids. The market for medical marijuana products, including flowers, concentrates, edibles, topicals, and tinctures, is expected to continue growing due to their potential therapeutic applications in treating conditions such as epilepsy, multiple sclerosis, anxiety, cancer, glaucoma, and insomnia.

Get a glance at the market report of share of various segments Request Free Sample

The Medical marijuana segment was valued at USD 9.19 billion in 2018 and showed a gradual increase during the forecast period. THC and CBD are the primary cannabinoids found in marijuana, with THC providing psychoactive effects and CBD offering therapeutic benefits without the high. Other cannabinoid-based products, such as Sativex, Marinol, Cesamet, and various cannabis-based products, are also gaining popularity for their medicinal applications. The legalization of marijuana for adult use in some states and continued clinical trials for various conditions are further fueling market growth.

Regional Analysis

North America is estimated to contribute 87% to the growth of the global market during the forecast period. Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period. In North America, the legalization of marijuana for medical use is gaining momentum. In the US and Canada, marijuana is authorized for thera

US Cannabis Market Outlook 2031:

The US cannabis market size size was valued at USD 13.20 Billion in 2022 and is projected to reach USD 43.61 Billion by 2031, expanding at a CAGR of 14.2% during the forecast period 2023 - 2031. The growth of the market is attributed to the common use of cannabis products for various applications in industries such as cosmetic, pharmaceutical, and food & beverage.



Despite its quasi-legal status, the market is expected to exhibit exponential growth due to gradual expansion of hemp legalization in several states in the country.



As more states approved marijuana legalization, the market has grown significantly in recent years. As of 2019, marijuana was made legal in 33 states and several states are under the process of legal approval of the products for medical, recreational, or both purposes. This has resulted in an increase in the number of business startups, which has aided in collectively driving the market.

Cannabis plant, a key source of marijuana, is widely adopted to treat patients having chronic illnesses including cancer, Parkinson's disease, Alzheimer's disease, and neurologic problems such as depression and epilepsy. According to a study published by the International Agency for Research on Cancer (IARC), the global burden of cancer was around 18.1 million new cases and 9.6 million deaths in 2018.



Keeping the view of surging illegal trade of cannabis products in the US, industrial companies and government officials are working towards for striking a balance between combating illegal marijuana usage and maintaining a safe and controlled supply. However, the country's illicit cannabis sector is thriving as items sold through illegal channels are costing less than those available in the market officially.



Furthermore, politicians are working towards resolving issues between federal and state regulations to curb stifle of the market growth. Owing to the unavailability of long-term banking solutions, cannabis businesses in the country have been forced to conduct transactions in cash, which has resulted in financial security issues such as money laundering.



States in the United States are addressing these issues by allowing cannabis credit co-operatives to aid business development to ensure accountability in the financial transaction related to cannabis trade. Section 280E of the federal tax code prohibits the deduction of ordinary business expenses related to the "trafficking" of Schedule I drugs.

According to Cognitive Market Research, the global Cannabis market size will be USD 58614.5 million in 2024. It will expand at the compound annual growth rate (CAGR) of 35.00% from the year 2024 to 2031.

North America held the primary market share for more than 40% of global revenue with a market size of USD 23445.80 million in 2024 and will rise at a compound annual growth rate (CAGR) of 33.2% from the year 2024 to 2031.
Europe accounted for a market share of over 30% of the global revenue with a market size of USD 17584.35 million.
Asia Pacific held a market share of around 23% of the global revenue with a market size of USD 13481.34 million in 2024 and will rise at the compound annual growth rate (CAGR) of 37.0% from the year 2024 to 2031.
Latin America held a market share of more than 5% of global revenue with a market size of USD 2930.73 million in 2024 and will rise at the compound annual growth rate (CAGR) of 34.4% from the year 2024 to 2031.
Middle East and Africa held a market share of around 2% of global revenue and estimated at a market size of USD 1172.29 million in 2024 and will rise at the compound annual growth rate (CAGR) of 34.7% from the year 2024 to 2031.
The concentrates category is the fastest growing segment of the Cannabis industry

Market Dynamics of Cannabis Market

Key Drivers for Cannabis Market

Increasing Legalization and Decriminalization of Cannabis to Boost Market Growth

The growing trend of cannabis legalization and decriminalization across various countries and states is a significant driving factor for the cannabis market. Governments are recognizing the economic potential of legal cannabis through tax revenues and job creation, leading to the gradual relaxation of laws surrounding its production, distribution, and consumption. Legalization has expanded access to medical and recreational cannabis, encouraging more consumers to explore its benefits. In regions like North America and Europe, regulatory shifts have fostered a thriving market for cannabis-based products, including oils, edibles, and topicals. This trend is also driving innovation, attracting investments, and minimizing the stigma associated with cannabis use, further boosting its adoption. As more countries follow suit, the global cannabis market is foreseen to rise significantly, propelled by both increased accessibility and consumer interest. For instance, CV Sciences, Inc. introduced its +PlusCBD reserve collection of extra gummies. The reserve collection product line offers a blend of full-spectrum cannabinoids capable of providing relief when intense support is required

Rising Demand for Medical Cannabis to Drive Market Growth

The increasing acceptance of cannabis for medical purposes is another major factor driving market growth. Scientific studies and clinical trials have highlighted the therapeutic benefits of cannabis compounds, particularly cannabidiol (CBD) and tetrahydrocannabinol (THC), in managing chronic pain, anxiety, epilepsy, and other conditions. This has led to growing prescriptions for cannabis-based medications in healthcare systems worldwide. The ageing global population and surging prevalence of chronic diseases have further spurred demand for medical cannabis as a natural and effective treatment option. The advancements in extraction technologies and product formulations have made cannabis-derived pharmaceuticals more accessible and standardized, enhancing their appeal among patients and healthcare professionals. With ongoing research and increasing acceptance, the medical cannabis segment is poised to play a pivotal role in the expansion of the overall cannabis market.

Restraint Factor for the Cannabis Market

Stringent Regulatory Frameworks and Legal Restrictions Will Limit Market Growth

The cannabis market faces significant restraints due to stringent regulatory frameworks and inconsistent legal statuses across different regions. While some countries and states have legalized medical or recreational cannabis, many others continue to impose strict prohibitions. Even in legalized areas, taxation policies, complex licensing requirements, and compliance costs pose challenges for market participants. These barriers limit market entry for smaller businesses and slow the expansion of cannabis-related products. Additionally, the lack of global standardization in regulations complicates international trade and investment opportunities. The stigma assoc...

Between 2021 and 2026, the cannabis market in Arizona is expected to grow by around 580 percent, while the cannabis market in Illinois is expected to grow by some 426 percent in the same period. This statistic illustrates select U.S. states with the highest projected cannabis market growth between 2021 and 2026.

BIS Research undertakes detailed study report on North America Cannabis Market. The report analyzes key market trends, study, size, players & opportunities.

The global medical cannabis market size reached USD 37.0 Billion in 2024. Looking forward, IMARC Group expects the market to reach USD 68.6 Billion by 2033, exhibiting a growth rate (CAGR) of 7.1% during 2025-2033. The increasing product use in treating substance use disorders, the exploration of products for chronic inflammatory conditions, the rising product demand for gastrointestinal disorders, and the rising demand for CBD-based products are some of the factors propelling the market.

IMARC Group provides an analysis of the key trends in each segment of the global medical cannabis market report, along with forecasts at the global, regional and country levels from 2025-2033. Our report has categorized the market based on species, derivatives, application, end-use and route of administration.

The US Cannabis Marijuana Market offers a diverse range of products, including marijuana flowers, oils, tinctures, hemp CBD, supplements, and industrial hemp. Marijuana flowers are a key product category, with different strains offering varying potencies and effects. Cannabis oils are highly concentrated extracts, providing a potent delivery method. Tinctures are liquid extracts that can be easily mixed into beverages or consumed sublingually. Hemp CBD products are derived from hemp plants and contain non-psychoactive cannabidiol (CBD), which has therapeutic properties without the psychoactive effects of tetrahydrocannabinol (THC). Industrial hemp is used for various non-drug applications, such as fiber production and biofuel. Notable trends are: Prolonged Legalization and Regulatory Developments are driving the market growth..

According to some projections for the United States, the medical cannabis market will reach a peak in 2024, with around 9.3 billion U.S. dollars. After that, a phase of stagnation and even decline is expected in the following years. This is partly because medical sales tend to fall when states start allowing adult-use sales after previously allowing medical-use sales.

Medical and recreational marijuana growing in the United States has experienced substantial growth, with industry revenue surging at a CAGR of 20.4% to reach $23.8 billion over the past five years, including a gain of 9.7% in 2024 alone. Legislative victories during the pivotal 2016 and 2020 elections have facilitated the approval of marijuana for both medical and recreational use in numerous states, contributing to this growth. The acceptance of medical and recreational marijuana has reached an overwhelming 88.0% among US adults, while 57.0% support full adult use legalization, as per a recent Pew Research Center survey. This growing acceptance has opened unprecedented opportunities for growers and investors, fundamentally reshaping the industry landscape. The profitability of marijuana growers has seen a marked increase. Influxes of new market entrants, particularly in states that have legalized recreational use, contributed to substantial revenue spikes, including a 39.6% increase in 2020 alone. Medical marijuana growers have benefitted from a growing aging population with higher incidences of chronic illnesses and cancer, further driving demand. The ongoing momentum for recreational marijuana legalization is expected to continue boosting profit, providing growers with the financial means to expand operations, invest in advanced cultivation technologies and develop diverse product lines. This economic growth has significantly impacted the overall profitability and stability of the industry. Looking ahead, industry revenue is projected to grow at a CAGR of 15.1% to $48.2 billion over the next five years. Although federal legalization remains uncertain, the expanding base of medical marijuana patients and the continuing movement toward recreational legalization are expected to sustain industry growth. Additionally, legalization trends in neighboring countries like Canada and Mexico could exert pressure on the United States federal government to reconsider its stance on marijuana. This evolving regulatory landscape, combined with increasing consumer demand, sets the stage for continued expansion. Consequently, the industry is poised to offer lucrative opportunities for both growers and investors, promising robust growth and innovation.

The USA legal marijuana market is reshaped by state-level legalization, consumer education, and medical adoption. Learn how federal restrictions and taxation impact industry growth.

North America Cannabis Market size, market share, focus on medical application, Distribution Channel, Market Share & North America Cannabis Market Analysis 2025, Market Size, Market Forecast, Market Trends, Market Growth.

US Cannabis Testing Services Market size is growing with a CAGR of 12.7% in the prediction period and it crosses USD 4.71 Bn by 2032 from USD 2.04 Bn in 2025.

According to cognitive market research, the global legal cannabis market size was valued at USD xx billion in 2024 and is expected to reach USD xx billion at a CAGR of xx% during the forecast period.

The legal cannabis market has experienced rapid growth, driven by the increasing legalization of cannabis for both medical and recreational use across various regions globally.
North America accounted for the largest revenue share of over xx% in 2024. Revenue generated is highly territorial owing to laws and policies on the trade of cannabis.
Asia is the fastest-growing regional market and is anticipated to register the fastest growth rate of xx%. This can be due to the increase in the acceptance of cannabis across different countries in the region.
The major players in the European market are extensively pursuing plans to maintain their positions and profit from the expansion of the sector.
The growing recognition of the therapeutic benefits of cannabis in the Middle East and Africa in treating chronic pain, epilepsy, and mental health disorders is propelling demand in the medical cannabis segment.
Major market participants who are essential in determining consumer preferences and market dynamics have a major impact on the legal cannabis market.

Market Dynamic of the Legal Cannabis Market

Key Drivers of the Legal Cannabis Market

The increasing legalization of cannabis will propel the market growth

As more countries and states legalize cannabis for medical and recreational use, the market continues to grow beyond wisdom and comprehension. This shift not only enhances the market’s growth for the industry but also breaks the barrier in terms of consumer acceptance of cannabis products. Moreover, rules and regulations set the policies and procedures that various enterprises must follow to maintain the quality and safety of products. Overall, the process of legalization and regulation still provides a large and important force pushing the cannabis market forward. There has been a growing popular movement in the United States to legalize marijuana for medicinal and recreational uses, with several states adopting such laws already. One motivation for legalization is the economic boon that can come from the regulated commercial availability. For instance, Ecuador has now legalized cannabis production. • For instance, In June 2021, the Cannabis Regulation Act (CRA) created a comprehensive licensing, taxing, and regulatory enforcement structure for the adult use of cannabis in New Mexico, and the US. The act would be administered by the Cannabis Control Division (CCD). According to the Act, adults aged 21 and over can possess up to 16 grams of extract, 2 ounces of flower, 800 mg infused edibles, and six mature plants. (Source:https://www.covasoftware.com/us-dispensary-laws/newmexico )

Ongoing medical research and innovation are influencing the growth of the cannabis market

The ongoing advancement in medical research and product development plays a major role in shaping the cannabis market due to the ever-increasing demand for medical cannabis products. Consumers rely on cannabis as the treatment for various medical conditions due to advancements in scientific knowledge about the therapeutic effects of cannabis. Technological improvements in the growth of plants also in the preparation of the products, as well as the methods of administration increase the effectiveness of medical marijuana and can be used by even a broader range of individuals including medical practitioners. • For instance, In August 2021, Tilary Inc., a global pioneer in the research, production, and distribution, announced the launch of medicinal hemp edibles in varieties of chocolates and soft chewing gums rich in THC and CBD. The new Tilary brand offers a wide range of medicinal cannabis products, including whole flowers, oils, vaporizers, and pre-rolls designed for the health and wellness of the patient. (Source:https://www.nasdaq.com/press-release/tilray-launches-new-medical-cannabis-edibles-in-canada-2021-08-05 )

Restraints of the Legal Cannabis Market

Market saturation and intense competition are emerging as significant restraints for the maket

Cannabis is increasingly legal for medical and recreational use in many states and countries; this has led to increased industry saturation with many firms e...

North America Cannabis Market is anticipated to grow at a CAGR of around 27.7% during the forecast period 2022-27.

Snapshot img

Cannabis Testing Market Size 2024-2028

The cannabis testing market size is forecast to increase by USD 2.05 billion at a CAGR of 15.23% between 2023 and 2028.

The market is experiencing significant growth due to various trends and factors. One of the primary drivers is the increasing use of cannabis for medical purposes, leading to a rise in demand for accurate and reliable testing services. Another trend is the emergence of luxury cannabis products, which require rigorous testing using high-performance liquid chromatography (HPLC) and chromatography to ensure consistency and quality. 
However, the high cost of analytical products poses a challenge for smaller players in the market. Producers and retailers must invest in advanced testing technologies to meet regulatory requirements and consumer demand for safe and effective cannabis products. .

What will be the Size of the Cannabis Testing Market During the Forecast Period?

Request Free Sample

The market is experiencing significant growth due to increasing demand for automation software and innovation in ensuring product safety and regulatory compliance. With a focus on accuracy and consumer safety, companies are investing heavily in research and development, data analysis, and training to stay ahead of industry trends. Automation and standardization of testing protocols are key priorities, enabling faster turnaround times and cost savings.



Sensitivity and specificity are crucial factors in cannabis testing, requiring advanced equipment and rigorous quality control measures. Safety and accreditation are paramount, driving the need for certification and adherence to best practices. Regulations continue to evolve, necessitating ongoing education and adaptation. Market analysis and data management are essential for understanding consumer preferences and staying competitive. Outsourcing testing services to specialized providers offers cost savings and expertise. The future of the market lies in continued innovation, ensuring traceability, and providing comprehensive reporting and chain of custody solutions.

How is this Cannabis Testing Industry segmented and which is the largest segment?

The cannabis testing industry research report provides comprehensive data (region-wise segment analysis), with forecasts and estimates in 'USD billion' for the period 2024-2028, as well as historical data from 2018-2022 for the following segments.

Product

  Consumables
  Instruments
  Software


End-user

  Cannabis cultivators/growers
  Cannabis drug manufacturers
  Others


Type

  Potency Testing
  Terpene Profiling
  Residual Solvent Screening
  Heavy Metal Testing
  Mycotoxin Testing
  Others


Geography

  North America

    Canada
    US


  Europe

    Germany
    UK


  Asia

    China


  Rest of World (ROW)

By Product Insights

The consumables segment is estimated to witness significant growth during the forecast period.

The market involves the utilization of analytical laboratories, instruments, and consumables for the analysis of cannabis and cannabis-infused products. This testing is essential to ensure product quality, potency, and consumer safety. Regulatory standards mandate the testing for pesticides, heavy metals, residual solvents, and contaminants. Chromatographic methods, such as gas and liquid chromatography, are commonly used for the testing of cannabinoid content, including cannabidiol (CBD) and tetrahydrocannabinol (THC). UV spectrometric analysis and mass spectrometry are also used for identifying and quantifying various cannabis compounds. The cannabis industry, including medical and adult use, requires rigorous testing processes to meet consumer demands and regulatory requirements. Sigma-Aldrich, a subsidiary of Merck, is a significant supplier of consumables, including glassware, labware, and reagents, for the market.

Get a glance at the Cannabis Testing Industry report of share of various segments Request Free Sample

The consumables segment was valued at USD 715.30 billion in 2018 and showed a gradual increase during the forecast period.

Regional Analysis

North America is estimated to contribute 49% to the growth of the global market during the forecast period.

Technavio's analysts have elaborately explained the regional trends and drivers that shape the market during the forecast period.

For more insights on the market share of various regions, Request Free Sample

The North American market dominates the global cannabis testing industry due to the legalization of cannabis for medical and adult use. The therapeutic potential of cannabis in alleviating symptoms of diseases such as epilepsy, cancer, and MS drives advocacy and political support. Countries like Canada are set to legalize cannabis for taxation. The market expansion in North America is primarily driven by the rising application of cannabis-infuse